SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001437749-22-008615
Filing Date
2022-04-08
Accepted
2022-04-08 17:05:09
Documents
3

Document Format Files

Seq Description Document Type Size
1 FORM DEFA14A dffn20220408_defa14a.htm DEFA14A 25259
2 EXHIBIT 99.1 ex_356623.htm EX-99.1 11740
3 image2.jpg GRAPHIC 8024
  Complete submission text file 0001437749-22-008615.txt   49470
Mailing Address 300 EAST MAIN STREET SUITE 201 CHARLOTTESVILLE VA 22902
Business Address 300 EAST MAIN STREET SUITE 201 CHARLOTTESVILLE VA 22902 (434) 220-0718
Diffusion Pharmaceuticals Inc. (Filer) CIK: 0001053691 (see all company filings)

IRS No.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37942 | Film No.: 22817773
SIC: 2834 Pharmaceutical Preparations